CERTARA INC. - COMMON
10,99
07-ноября-24 15:59:58
15 мин. задержка
Акции
+0,08
+0,73%
Сегодняшний диапазон
10,08 - 11,02
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 8th Consecutive Year
15 фев 2022 16:30:00 Источник Nasdaq GlobeNewswire
-
Certara to Report Fourth Quarter and Full Year 2021 Financial Results on March 1st, 2022
08 фев 2022 16:30:00 Источник Nasdaq GlobeNewswire
-
21 дек 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Certara Announces Release of Pinnacle 21 Enterprise Software
13 дек 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Certara to Host Investor Day on December 15, 2021
08 дек 2021 17:00:00 Источник Nasdaq GlobeNewswire
-
02 дек 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Certara Announces Update of D360™ Scientific Informatics Software
29 ноя 2021 16:30:00 Источник Nasdaq GlobeNewswire
-
Certara Announces Closing of Public Offering of Common Stock
22 ноя 2021 17:45:00 Источник Nasdaq GlobeNewswire
-
Certara Announces Pricing of Public Offering of Common Stock
17 ноя 2021 23:27:02 Источник Nasdaq GlobeNewswire
-
Certara Announces Proposed Public Offering of Common Stock
15 ноя 2021 17:30:00 Источник Nasdaq GlobeNewswire
-
Certara Reports Third Quarter 2021 Financial Results
09 ноя 2021 16:10:00 Источник Nasdaq GlobeNewswire
-
Certara Appoints James E. Cashman III as Chairman of Board of Directors
08 ноя 2021 16:30:00 Источник Nasdaq GlobeNewswire
-
Certara to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference
03 ноя 2021 08:00:00 Источник Nasdaq GlobeNewswire
-
Pinnacle 21 Awarded FDA Contract for 5 Years for Software and Services
28 окт 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award
25 окт 2021 16:30:00 Источник Nasdaq GlobeNewswire
-
Certara to Report Third Quarter 2021 Financial Results on November 9th, 2021
19 окт 2021 08:00:02 Источник Nasdaq GlobeNewswire
-
Certara Appoints Patrick F. Smith to President of Integrated Drug Development
12 окт 2021 08:00:02 Источник Nasdaq GlobeNewswire
-
Certara Appoints Drayton T. Virkler as Chief Commercial Officer
05 окт 2021 08:00:02 Источник Nasdaq GlobeNewswire
-
Certara Completes Acquisition of Pinnacle 21
04 окт 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Certara Launches New Synchrogenix™ Writer Software to Accelerate the Regulatory Submission Process
30 сен 2021 16:30:00 Источник Nasdaq GlobeNewswire